Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide
- 1 December 1979
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 48 (2) , 369-374
- https://doi.org/10.1016/0008-8749(79)90131-x
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Macrophage activation for tumor cytotoxicity: Tumoricidal activity by macrophages from C3H/HeJ mice requires at least two activation stimuliCellular Immunology, 1978
- The macrophage, target cell of the synthetic adjuvant muramyl dipeptideEuropean Journal of Immunology, 1978
- In vitro spleen cell responsiveness to various analogs of MDP (N-acetylmuramyl-l-alanyl-d-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder miceCellular Immunology, 1978
- Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors.The Journal of Experimental Medicine, 1977
- Interferon: An Inducer of Macrophage Activation by PolyanionsScience, 1977
- Macrophage Tumor Killing: Influence of the Local EnvironmentScience, 1977
- Genetic defect in responsiveness to the B cell mitogen lipopolysaccharideEuropean Journal of Immunology, 1977
- Target cells for the activity of a synthetic adjuvant: Muramyl dipeptideCellular Immunology, 1977
- Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble componentsCellular Immunology, 1976
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974